Cellular Goods PLC (CBX)

London
5.60
-0.08(-1.41%)
  • Volume:
    2,021,964
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    5.70 - 5.70

CBX Overview

Prev. Close
5.68
Day's Range
5.7-5.7
Revenue
-
Open
5.6
52 wk Range
5-30
EPS
-
Volume
2,021,964
Market Cap
28.67M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,941,928
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
504,750,000
Next Earnings Date
-
What is your sentiment on Cellular Goods PLC?
or
Market is currently closed. Voting is open during market hours.

Cellular Goods PLC News

Cellular Goods PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellSell
Technical IndicatorsStrong BuyNeutralSellStrong SellNeutral
SummaryBuyNeutralSellStrong SellNeutral

Cellular Goods PLC Company Profile

Cellular Goods PLC Company Profile

Cellular Goods PLC is a United Kingdom-based consumer cannabinoid company. The Company is a provider of consumer products based on biosynthetic cannabinoids. The Company focuses on two product verticals: premium skincare and topical athletic recovery products. Its products are offered through partnerships with online and physical retailers and direct to consumers through the Company's Website.

Read More
  • Ethereum MAX going to sky rocket. (eMax) you here it hear first. Have a good weekend.
    0
    • a IPO has just been released for PensionBee £1.55 p/s.  Only on offer to customers at the moment.  Looks interesting, something I'll be keeping an eye on.
      2
      • They need to emphasise product safety more.
        0
        • it's holding nice and steady now which is good to see, solid foundations is what is needed.
          0
          • To the moon 😅
            2
            • The most common mechanisms leading to death following synthetic cannabinoid use include behavioral risks, such as self-harm and suicide, falling from a height, and wandering into traffic; cardiovascular effects; and central nervous system depression.
              19
              • There have been several deaths linked to synthetic cannabinoids. The Centers for Disease Control and Prevention (CDC) found that the number of deaths from synthetic cannabinoid use tripled between 2014 and 2015.[9][10] In 2018, the United States Food and Drug Administration warned of significant health risks from synthetic cannabinoid products that contain the rat poison brodifacoum, which is added because it is thought to extend the duration of the drugs' effects.[11] Severe illnesses and death have resulted from this contamination.[11]
                18
                • Even if true, a miniscule fraction compared deaths caused by alcohol, cigarettes and recreational drugs without a doubt! Drink enough water and that will also cause death! Stop your scaremongering!
                  0
              • Where can I buy CBXs products?  Can't find anything online!
                2
                • That's because they've yet to develop any. I would have thought they'd need a few bio-chemists to liaise with their prospective suppliers of the synthetic material in the USA. Instead they seem to have several managers and financial consultants.
                  2
              • I’m still waiting for my shares to show in my broker account. This is despite me purchasing via Primary Bid well in advance of the floatation date. Can I assume that I am not alone on this?
                0
                • Nippon Alam I saw it was 13x oversubscribed. I was going to buy some, only to sell on the first day of listing, but the offer closed early and I missed it.
                  0
                • Uncle Bulgariawas scaled back. I tried to buy £16k. Got £900ish worth. Which was fair enough.
                  0
                • Drew Siebo so, no one bought the minimum of 100 ?
                  0
              • From the Path Finder Document: -   16.) Intellectual property The Company is not dependent on  [= does not have] any patents or licences, industrial, commercial or financial contracts, or new manufacturing processes, where such are of fundamental importance to the Company’s business or profitability. 17.) Premises The Company does not own any premises or hold any leasehold interests in any properties. 18.) Employees The Company currently employs five people including the executive directors and currently engages four nonexecutive directors and six consultants.
                0
                • Down she goes, just like the Titanic!
                  0
                  • it's moving down :-)
                    1
                    • it's moving up :-)
                      2
                      • I wonder if Beckham sold at 20p
                        6
                        • Well, new shares were created in the IPO funding to raise the £13m at 5p. The number of shares is limited, so the share-price on the initial day of trading on the LSE was determined by how strongly those who had those shares wanted to keep hold of them or sell them and by those who were desperate to buy, with the demand created by publicity.. Some of the company's management are prohibited from selling their shares for a periods of a year or so, but I would imagine that most of the institutional investors, including DB ventures would have off-loaded most of their shares. That's how the game works.
                          0
                        • Locked in for a year
                          0
                        • Somehow I think he does not need the money.
                          0
                      • What exchange do I use to purchase to this stock?
                        0
                        • Halifax shares and dealings
                          0
                        • Theyre on LSE
                          0
                      • If it goes to 15p a share that will be a good time to buy a slice of the pie.
                        1
                        • at 20p. it was oversold, based on the company's business plan. They have no products, no IP, just DB's name behind them.
                          5
                          • You're right I suppose.  Potential is good and Peter Wall gave it a shout out.  I'll keep an eye on it.
                            1
                        • Buy in the dips, this has good time to climb over time.
                          1
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.